Pamrevlumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Pamrevlumab
Monoclonal antibody
Type ?
Source Human
Target CTGF
Clinical data
Synonyms FG-3019
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
Formula C6492H10018N1718O2086S48
Molar mass 147.0 g/mol

Pamrevlumab (INN[1]) (FG-3019) is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer.

This drug was developed by FibroGen, Inc.[2]

References[edit]